201 related articles for article (PubMed ID: 1851998)
21. Renal and depressor activities of inhibitors of neutral endopeptidase and angiotensin converting enzyme in monkeys infused with angiotensin II.
Seymour AA; Asaad MM; Abboa-Offei BE; Smith PL; Mathers PD; Rogers WL; Dorso CR
J Cardiovasc Pharmacol; 1996 Nov; 28(5):651-8. PubMed ID: 8945678
[TBL] [Abstract][Full Text] [Related]
22. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
[TBL] [Abstract][Full Text] [Related]
23. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
Seymour AA; Asaad MM; Abboa-Offei BE; Smith PL; Rogers WL; Dorso CR
J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340
[TBL] [Abstract][Full Text] [Related]
24. Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction.
Marie C; Mossiat C; Gros C; Schwartz JC; Lecomte JM; Bralet J
Cardiovasc Res; 1999 Mar; 41(3):544-53. PubMed ID: 10435026
[TBL] [Abstract][Full Text] [Related]
25. In vivo properties of thiol inhibitors of the three vasopeptidases NEP, ACE and ECE are improved by introduction of a 7-azatryptophan in P2' position.
Inguimbert N; Poras H; Dhotel H; Beslot F; Scalbert E; Bennejean C; Renard P; Fournié-Zaluski MC; Roques BP
J Pept Res; 2004 Feb; 63(2):99-107. PubMed ID: 15009531
[TBL] [Abstract][Full Text] [Related]
26. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes.
Helin K; Tikkanen I; Hohenthal U; Fyhrquist F
Eur J Pharmacol; 1994 Oct; 264(2):135-41. PubMed ID: 7851475
[TBL] [Abstract][Full Text] [Related]
28. [Dual inhibition of converting enzyme and neutral endopeptidase: a research new way in the field of hypertension].
Fournie-Zaluski MC
C R Seances Soc Biol Fil; 1992; 186(6):612-25. PubMed ID: 1339591
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
[TBL] [Abstract][Full Text] [Related]
30. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
[TBL] [Abstract][Full Text] [Related]
31. Vasopeptidase inhibition: a new concept in blood pressure management.
Burnett JC
J Hypertens Suppl; 1999 Feb; 17(1):S37-43. PubMed ID: 10340842
[TBL] [Abstract][Full Text] [Related]
32. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
[TBL] [Abstract][Full Text] [Related]
33. Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
J Cardiovasc Pharmacol; 1998 Jan; 31(1):116-25. PubMed ID: 9456286
[TBL] [Abstract][Full Text] [Related]
34. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
Gonzalez W; Beslot F; Laboulandine I; Fournié-Zaluski MC; Roques BP; Michel JB
J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
Chatelain RE; Ghai RD; Trapani AJ; Odorico LM; Dardik BN; De Lombaert S; Lappe RW; Fink CA
J Pharmacol Exp Ther; 1998 Mar; 284(3):974-82. PubMed ID: 9495857
[TBL] [Abstract][Full Text] [Related]
37. New enkephalinase inhibitors as probes to differentiate "enkephalinase" and angiotensin-converting-enzyme active sites.
Roques BP; Fournié-Zaluski MC; Florentin D; Waksman G; Sassi A; Chaillet P; Collado H; Costentin J
Life Sci; 1982 Oct 18-25; 31(16-17):1749-52. PubMed ID: 6296575
[No Abstract] [Full Text] [Related]
38. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
[TBL] [Abstract][Full Text] [Related]
39. Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: role of enkephalinase (EC 3.4.24.11).
Gros C; Souque A; Schwartz JC
Neuropeptides; 1990 Sep; 17(1):1-5. PubMed ID: 2148814
[TBL] [Abstract][Full Text] [Related]
40. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
Checler F; Vincent JP; Kitabgi P
J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
